Chemomab Therapeutics Ltd., a clinical stage biotechnology company developing innovative therapeutics to treat rare fibro-inflammatory diseases with high unmet need, announced it will host a live key opinion leader virtual event on primary sclerosing cholangitis on Wednesday, April 10, 2024 at 10:00 AM ET.
April 2, 2024
· 5 min read